Business / Finance

RSS

Lab21 acquires Microgen Bioproducts

Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine and clinical diagnostics, has announced that it has acquired Microgen Bioproducts Ltd a UK company specialising in the development, manufacture and sale of diagnostic tests to identify diseases and organisms which pose a threat to health.

6 Jan 2011

Renal Advantage, Liberty Dialysis announce deal closure

Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal. The transaction – terms of which were not disclosed – was completed on December 17, 2010. The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.

23 Dec 2010

Cerner, Baxa sign strategic reseller agreement for DoseEdge Pharmacy Workflow Manager

Cerner Corporation and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge Pharmacy Workflow Manager. The agreement enables Cerner to market and resell the Baxa DoseEdge System as part of an integrated Cerner offering. Cerner clients now have access to a broader suite of solutions and certified integration for dose tracking from compounding to delivery.

6 Dec 2010

Hybrigenics receives EUR 800,000 payment from Oseo

Hybrigenics (ALHYG), a bio-pharmaceutical group with a focus on research and development of new cancer treatments and a fully-owned subsidiary specialized in protein interactions services, today announces it has received EUR 800,000 as the second and last payment of a EUR 1.4 million refundable grant contract originally signed with France’s innovation agency, Oseo Innovation, in 2008.

2 Dec 2010

GFS solution to Cholera

GFS BioProtect™ Effluent Remediator kills Vibrio cholerae O: 1, serotype Ogawa to Log 3 immediately, and the kill rate for this and several other pathogens continues to improve over time. The product breaks down B Class biomass (latrine and septic tank waste) into A class biomass suitable for reuse.

28 Nov 2010

Pharma enhances its focus on Asia-Pacific partnerships

While the Japanese market still dominates deal activities in the Asia-Pacific (APAC) region, companies and research institutes in emerging APAC countries have recently been attracting high calibre collaborators, according to the latest analysis by Datamonitor.

28 Nov 2010

Patrys announces capital raising of $3.2 million and share purchase plan

Patrys Limited (ASX: PAB; Company), a biotechnology company focused on the development of revolutionary new treatments for cancer, is pleased to announce a successful capital raising of approximately $3.2 million, which was conducted via a private placement.

16 Nov 2010